NCT00671190 - Safety and Efficacy of Ramelteon in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

Sleep Disorder

Interventions

DRUG

Ramelteon

Ramelteon 1 mg, tablets, orally once daily for up to 5 days

DRUG

Ramelteon

Ramelteon 2 mg, tablets, orally once daily for up to 5 days

DRUG

Ramelteon

Ramelteon 4 mg, tablets, orally once daily for up to 5 days

DRUG

Ramelteon

Ramelteon 8 mg, tablets, orally once daily for up to 5 days

DRUG

Placebo

Ramelteon placebo-matching tablets, orally once daily for up to 5 days

Trial Locations (13)

Hot Springs

Los Angeles

San Diego

Miami

Atlanta

Macon

Danville

Overland Park

Metairie

Chevy Chase

Las Vegas

Dublin

Columbia